Jennifer Lin has in-depth practice experience in intellectual property, life sciences, and regulatory compliance in the pan-Asia region. She has assisted in intellectual property prosecution, enforcement, and commercialization in China and Hong Kong S.A.R. and has advised on multiple IP-related transactions including M&A, licensing, joint ventures, and other types of deals for clients from various industries such as Greystar, Henderson, Junshi, Incyte, Moody's, Stonepeak, and Sumitomo Dainippon Pharma.
As a PRC qualified lawyer based in Hong Kong, Jennifer has advised leading pharmaceutical and medical device companies on China's regulatory and compliance regimes in a wide range of legal aspects, including clinical trials, market authorization, human genetic resources, and data exportation. In addition, she has assisted clients that have significant business operations and interests in China and Hong Kong in compliance and risk management of cybersecurity, privacy, and data protection. She also has managed domestic trademark portfolios of Fortune 500 companies and prosecuted Hong Kong standard patents for multiple global biotech and pharmaceutical companies.
Prior to joining to Jones Day in 2019, Jennifer worked for a large Chinese law firm and represented clients in trademark, copyright, and patent disputes in Chinese courts. A copyright and unfair competition case that Jennifer extensively worked on was ranked as one of China's "Top 10 Most Study-Worthy IP Adjudications in 2018" by the Shanghai Intellectual Property Academy, which a favorable decision was later affirmed by the Guangzhou IP Court in 2023.
Palestras / Aulas
- October 7, 2021
Protection of Trademarks and Intellectual Property in China
- The University of Hong Kong (LL.M. in Intellectual Property and Information Technology 2019; Research Assistant, Law & Technology Centre); Guangdong University of Foreign Studies (LL.B. and B.A. in English 2016, with first class honors)
- Hong Kong (Registered Foreign Lawyer, PRC)